Suppr超能文献

单剂量硫酸皮肤素对人体纤溶系统的影响以及九次每日剂量的促纤溶作用。

Effect of a single dose of mesoglycan on the human fibrinolytic system, and the profibrinolytic action of nine daily doses.

作者信息

Vittoria A, Messa G L, Frigerio C, Celasco G, Auteri A

机构信息

Istituto di Patologia Speciale Medica, University of Siena, Italy.

出版信息

Int J Tissue React. 1988;10(4):261-6.

PMID:2977981
Abstract

The profibrinolytic activity of orally administered Mesoglycan was evaluated in 18 patients affected by impaired plasma fibrinolytic activity. Mesoglycan was administered by a single oral dose of 24, 48 or 72 mg on 1 day, and by repeated doses of 48 mg twice a day for 9 consecutive days. After the single administration all the fibrinolytic parameters were significantly and positively influenced with an order of magnitude and a duration of effects proportional to the dose employed. After the repeated administration, a constant and reproducible activation of the fibrinolytic system was observed without any interference with haemocoagulative parameters. These results confirm that Mesoglycan is endowed with a relevant profibrinolytic activity in man after oral administration. The pharmacological activity of Mesoglycan could possibly involve the liberation of a certain amount of plasminogen tissue activator.

摘要

在18名血浆纤溶活性受损的患者中评估了口服葡糖胺聚糖的促纤溶活性。葡糖胺聚糖于第1天单次口服给予24、48或72mg,或连续9天每天两次重复给予48mg。单次给药后,所有纤溶参数均受到显著的正向影响,其影响程度和持续时间与所用剂量成正比。重复给药后,观察到纤溶系统持续且可重复的激活,而对血液凝固参数无任何干扰。这些结果证实,葡糖胺聚糖口服给药后在人体内具有显著的促纤溶活性。葡糖胺聚糖的药理活性可能涉及一定量纤溶酶原组织激活剂的释放。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验